Aberrant HGF/c-Met signalling has been well documented in a variety of human cancers (Maulik et al, 2002), and our results strengthen the view that also the gastrin signalling pathway could be involved in oncogenesis (Waldum et al, 1995; Dockray et al, 2001). This evidence concerns the gene MET and cancer.